Sinju Thomas/LinkedIn
Mar 13, 2026, 16:47
Sinju Thomas: Combined Red Cell and Plasma Exchange for Severe FES in Sickle Cell Disease
Sinju Thomas, JACIE Inspector at The EBMT, Lead Apheresis Nurse Practitioner and Collection Facilility Director For Aoheresis at Imperial College Healthcare NHS Trust, shared a post on LinkedIn:
“Proud to present at the West London HCC Study Day on fat embolism syndrome (FES) a rare but devastating complication of sickle cell disease.
Early recognition saves lives.
We shared our experience using combined red cell exchange and plasma exchange as a promising rescue therapy for severe FES.
Grateful to be part of ongoing work to improve outcomes for people living with SCD.”
Stay updated with Hemostasis Today.
-
Apr 29, 2026, 07:12Matteo Foschi: Is There a Benefit to Switching DOACs After Breakthrough Stroke?
-
Apr 29, 2026, 07:02Enrico Ferro: Stroke Risk in PFA vs Radiofrequency Ablation
-
Apr 29, 2026, 06:03Proud to Recognize 6 Early Career Investigators as the Recipients of the 2026 JTH Editors’ Awards – JTH
-
Apr 29, 2026, 05:55On Hemophilia Care Advances, Collaboration and Access in India at IHC X 2026 – Hemophilia Federation India
-
Apr 29, 2026, 05:46Rajendra Tapadia: Strengthening Last-Mile Hemophilia Care Through Structured Community Outreach
-
Apr 29, 2026, 05:37Masoabi Sefojane: Whose Realities Shape Global Priorities in Hemophilia Care?
-
Apr 29, 2026, 05:24Filippo Cademartiri: Mandatory Reading for Anyone Who Mistakes Expertise for Certainty
-
Apr 29, 2026, 02:52Fengqian Chen: Another Reality Check for the Factor XI Inhibitor Race – Novartis’ Abelacimab Setback
-
Apr 29, 2026, 02:18Arnaud Baldivia: Peri-Procedural Stroke – An Underestimated Emergency in the Operating Room and in the ICU